Cited by 237Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

BROWN ADIPOSE TISSUE, β3-ADRENERGIC RECEPTORS, AND OBESITY

Lowell, MD, PhD, B. B., Flier, MD, J. S.·1997·Annual Review of Medicine

Abstract

Brown adipose tissue is distinguished by its unique capacity for uncoupled mitochondrial respiration, which is highly regulated by sympathetic nerve activity. Because of this, energy expenditure in brown fat is capable of ranging over many orders of magnitude. The fact that the function of brown adipose tissue is impaired in obese rodents and that transgenic mice with decreased brown fat develop obesity demonstrates the importance of brown fat in maintaining nutritional homeostasis. However, the role of brown fat in humans is less clear. beta 3-Adrenergic receptors are found on brown adipocytes, and treatment with beta 3-selective agonists markedly increases energy expenditure and decreases obesity in rodents. Whether beta 3-selective agonists will be effective anti-obesity agents in humans is presently under investigation.

Integrity signals

Registry

Crossref · 10.1146/annurev.med.48.1.307

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lowell, M., & Flier, M.
Affiliations
Division of Endocrinology, Department of Medicine, Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts 02215;, and
Venue
Annual Review of Medicine
Published
1997-02
Volume
48
Issue
1
Pages
307-316
ISSN
  • 0066-4219 (ISSN-L)
  • 1545-326X
OpenAlex
W2033159113
Cited by
237
References
70
Citations by year
2026: 4 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 8 · 2021: 15 · 2020: 9 · 2019: 5 · 2018: 15 · 2017: 11 · 2016: 10 · 2015: 10 · 2014: 10 · 2013: 6 · 2012: 8
FWCI
2.06
Type
journal article
Language
en
Open access
closed
Locations
  • Annual Review of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5k08dk002119-05, 5r01dk046930-10)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 46930, DK 49569, R01DK049569, DK-02119)
Topics
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
brown adipose tissue, beta3-adrenergic receptor, obesity, energy expenditure, sympathetic nervous system, brown adipocytes, anti-obesity drugs, nutritional homeostasis
MeSH terms
Animals, Adipose Tissue, Brown, Energy Metabolism, Humans, Mice, Obese, Mice, Transgenic, Obesity, Receptors, Adrenergic, beta, Receptors, Adrenergic, beta-3, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review